Haplo-BMT: Cure or back to sickle cell?

摘要

In this issue of Blood, Bola?os-Meade et al report promising results using a pioneering HLA-haploidentical bone marrow transplantation protocol in adults with sickle cell disease (SCD), including nonmyeloablative conditioning and posttransplantation high-dose cyclophosphamide.